Praxis Precision Medicines Inc PRAX:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EST
37.06quote price arrow down-4.45 (-10.72%)
Volume
205,579
52 week range
23.90 - 60.95

...

Loading . . .

KEY STATS

  • Open42.00
  • Day High43.53
  • Day Low36.54
  • Prev Close41.51
  • 52 Week High60.95
  • 52 Week High Date01/08/21
  • 52 Week Low23.90
  • 52 Week Low Date11/10/20
  • Market Cap1.418B
  • Shares Out38.26M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-31.08
  • Fwd P/E (NTM)-21.48
  • EBITDA (MRQ)-43.71M
  • ROE (MRQ)-
  • Revenue (MRQ)0.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Praxis Precision Medicines Inc News

There is no recent news for this security.

Latest PRAX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance. Its development stage products include PRAX-114, PRAX-944 and PRAX-562. PRAX-114 is an extrasynaptic-preferring gamma-aminobutyric acid-A (GABAA) receptor positive allosteric modulator (PAM) for the treatment of patients suffering...
Marcio Souza
President
Address
One Broadway, 16Th Floor
Cambridge, MA
02142
United States